GlassScriptPhysician profile
Tjorvi E Perry
NPI 1457395246
$122,764.43
in general payments reported to CMS, 2019-2025
4 companies · $63K in 2025
The $63K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $13K · 2021: $3,303 · 2022: $27K · 2023: $6,957 · 2025: $63K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $57K · Travel and Lodging: $12K · Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $56,758.25 |
| Travel and Lodging | $11,788.90 |
| Food and Beverage | $941.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $77,421.34 | 2020-2025 | Fibryga, Fibryga & Balfaxar |
| Edwards Lifesciences Corporation | $45,203.76 | 2019-2022 | |
| Hemosonics LLC | $73.98 | 2022 | |
| Becton, Dickinson and Company | $65.35 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tjorvi Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.